Pro-apoptotic activity of ergosterol peroxide and (22E)-ergosta-7,22-dien-5α-hydroxy-3,6-dione in human prostate cancer cells

Chemico-Biological Interactions

Volumn 184, Issue 3, 2010, Pages 352-358

  Russo, A ^a   Cardile, V ^a   Piovano, M ^b   Caggia, S ^a   Espinoza, C L ^b   Garbarino, J A ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b DEPARTAMENTO DE FÍSICA   (Chile)

Author keywords

Apoptosis; Cell vitality; DU 145 cells; Ergosterol peroxide; LNCaP cells; Prostate cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; ERGOSTA 7,22 DIEN 5ALPHA HYDROXY 3,6 DIONE; ERGOSTEROL; ERGOSTEROL PEROXIDE; GENOMIC DNA; LACTATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; COMET ASSAY; ERGOSTEROL; HUMANS; IN SITU NICK-END LABELING; LACTATE DEHYDROGENASES; MALE; PROSTATIC NEOPLASMS;

BASIDIOMYCOTA;

EID: 77949915554     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.01.032     Document Type: Article

References (54)

1. Lucas E.H., Montesano R., Pepper M.S., Hafner M., Sablon E. Tumor inhibitors in Boletus edulis and other holobasidiomycetes. Antibiot. Chemother. 1957, 7:1-4.
2. Wasser S.P., Weis A.L. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit. Rev. Immunol. 1999, 19:65-96.
3. Zaidman B.Z., Yassin M., Mahajna J., Wasser S.P. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl. Microbiol. Biotechnol. 2005, 67:453-468.
4. Russo A., Piovano M., Clericuzio M., Lombardo L., Tabasso S., Chamy M.C., Vidari G., Cardile V., Vita-Finzi P., Garbarino J.A. Putrescine-1,4-dicinnamide from Pholiota spumosa (Basidiomycetes) inhibits cell growth of human prostate cancer cells. Phytomedicine 2007, 14:185-191.
5. Clericuzio M., Tabasso S., Garbarino J.A., Piovano M., Cardile V., Russo A., Vidari G. Non-phenolic dicinnamides from Pholiota spumosa: isolation, synthesis and antitumor activity. Eur. J. Org. Chem. 2007, 2007:5551-5559.
6. Guyton K.Z., Kensler T.W., Posner G.H. Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutr. Rev. 2003, 61:227-238.
7. Kim D.S., Baek N.I., Oh S.R., Jung K.Y., Lee I.S., Kim J.H., Lee H.K. Anticomplementary activity of ergosterol peroxide from Naematoloma fasciculare and reassignment of NMR data. Arch. Pharmacol. Res. 1997, 20:201-205.
8. Piovano M., Guzman G., Garbarino J.A., Chamy M.C. The chemistry of Bacidia stipata (Lichens, Ascomycotina). Biochem. System. Ecol. 1999, 27:663-664.
9. Arisawa M., Fujita A., Saga M., Fukumura H., Hayashi T., Shimizu M., Morita N. Three new lanostanoids from Ganoderma lucidum. J. Nat. Prod. 1986, 49:621-625.
10. Sgarbi D.B., da Silva A.J., Carlos I.Z., Silva C.L., Angluster J., Alviano C.S. Isolation of ergosterol peroxide and its reversion to ergosterol in the pathogenic fungus Sporothrix schenckii. Mycopathologia 1997, 139:9-14.
11. Bok J.W., Lermer L., Chilton J., Klingeman H.G., Towers G.H. Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry 1999, 51:891-898.
12. Lindequist U., Teuscher E., Wolf B., Volsgen A., Hoffmann S., Kutschabsky L., Franke P., Seefeldt R. Isolation, characterization and structure elucidation of a substance with immunosuppressive action from Tricholoma populinum Lange. Pharmazie 1989, 44:165.
13. Fujimoto H., Nakayama M., Nakayama Y., Yamazaki M. Isolation and characterization of immunosuppressive components of three mushrooms, Pisolithus tinctorius, Microporus flabelliformis and Lenzites betulina. Chem. Pharm. Bull. 1994, 42:694-697.
14. Kreisel H., Lindequist U., Horak M., Distribution ecology, and immunosuppressive properties of Tricholoma populinum (Basidiomycetes). Zentralbl. Mikrobiol. 1990, 145:393-396.
15. Lindequist U., Lesnau A., Teuscher E., Pilgrim H. The antiviral action of ergosterol peroxide. Pharmazie 1989, 44:579-580.
16. Nakanishi T., Murata H., Inatomi Y., Inada A., Murata J., Lang F.A., Yamasaki K., Nakano M., Kawahata T., Mori H., Otake T. Screening of anti-HIV-1 activity of North American plants. Anti-HIV-1 activities of plant extracts, and active components of Lethalia vulpina (L.) Hue. Nat. Med. (Tokyo) 1998, 52:521-526.
17. Yasukawa K., Akihisa T., Kanno H., Kaminaga T., Izumida M., Sakoh T., Tamura T., Takido M. Inhibitory effects of sterols isolated from Chlorella vulgaris on 12-0-tetradecanoylphorbol-13-acetate-induced inflammation and tumor promotion in mouse skin. Biol. Pharm. Bull. 1996, 19:573-576.
18. Piovano M., Chamy M.C., Garbarino J.A., Quilhot W. Studies on Chilean Lichens. XXIV. Secondary products from Dyctionema glabratum (Basidiomycetina). Bol. Soc. Chil. Quim. 1995, 40:163-165.
19. Piovano M., Chamy M.C., Garbarino J.A., Lopez C., Quilhot W. Studies on Chilean Lichens. XXV. Secondary products from Leioderma pycnophorum N. y L. (Pannariaceae). Bol. Soc. Chil. Quim. 1995, 40:437-439.
20. Mossman B.T., Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med. 1998, 157:1666-1680.
21. Russo A., Piovano M., Lombardo L., Garbarino J., Cardile V. Lichen metabolites prevent UV light and nitric oxide-mediated plasmid DNA damage and induce apoptosis in human melanoma cells. Life Sci. 2008, 83:468-474.
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
23. Singh N.P., Tice R.R., Stephens R.E., Scheneider E.L. A microgel electrophoresis technique for the direct quantitation of DNA damage and repair in individual fibroblasts cultured on microscope slides. Mutat. Res. 1991, 252:289-296.
24. Baigi M.G., Brault L., Nequesque A., Beley M., Hilali R.E., Gauzere F., Bagrel D. Apoptosis/necrosis switch in two different cancer cell lines: influence of benzoquinone-and hydrogen peroxide-induced oxidative stress intensity, and glutathione. Toxicol. In Vitro 2008, 22:1547-1554.
25. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 2002, 9:459-470.
26. Bednarek I., Sypniewski D., Klama-Baryła A., Gałka S., Machnik G. Single-cell gel electrophoresis (comet assay) as a tool for apoptosis determination in tumor cell lines HL-60 and Jurkat cultures treated with anisomycin. Ann. Acad. Med. 2006, 60:278-284.
27. Godard T., Deslandes E., Lebailly P., Vigreux C., Sichel F., Poul J.M., Gauduchon P. Early detection of staurosporine-induced apoptosis by comet and annexin V assays. Histochem. Cell Biol. 1999, 112:155-161.
28. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., Feuer E.J., Thun M.J. Cancer statistics. CA Cancer J. Clin. 2004, 54:8-29.
29. Brawley O.W., Barnes S., Parnes H. The future of prostate cancer prevention. Ann. N.Y. Acad. Sci. 2001, 952:145-152.
30. Feldman B.J., Feldman D. The development of androgen-independent prostate cancer. Nat. Rev. Cancer 2001, 1:34-45.
31. Rangel C., Matzkin H., Soloway M.S. Experience with weekly doxorubicin (adriamycin) in hormone-refractory stage D2 prostate cancer. Urology 1992, 39:577-582.
32. Hussain M.H., Pienta K.J., Redman B.G., Cummings G.D., Flaherty L.E. Oral etoposide in the treatment of hormone-refractory prostate cancer. Cancer 1994, 74:100-103.
33. Roth B.J., Yeap B.Y., Wilding G., Kasimis B., McLeod D., Loehrer P.J. Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the Eastern Cooperative Oncology Group. Cancer 1993, 72:2457-2460.
34. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3:768-780.
35. Cardile V., Scifo C., Russo A., Falsaperla M., Morgia G., Motta M., Renis M., Imbriani E., Silvestre G. Involvement of HSP70 in resveratrol-induced apoptosis of human prostate cancer. Anticancer Res. 2003, 23:4921-4926.
36. Scifo C., Cardile V., Russo A., Consoli R., Vancheri C., Capasso F., Vanella A., Renis M. Resveratrol and propolis as necrosis or apoptosis inducers in human prostate carcinoma cells. Oncol. Res. 2004, 14:415-426.
37. Yim D., Singh R.P., Agarwal C., Lee S., Chi H., Agarwal R. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells. Cancer Res. 2005, 65:1035-1044.
38. Mohanty N.K., Saxena S., Singh U.P., Goyal N.K., Arora R.P. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia. Urol. Oncol. 2005, 23:383-385.
39. Bonham M., Posakony J., Coleman I., Montgomery B., Simon J., Nelson P.S. Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma. Clin. Cancer Res. 2005, 11:3905-3914.
40. Barnes S. Role of phytochemicals in prevention and treatment of prostate cancer. Epidemiol. Rev. 2001, 23:102-105.
41. Schwartz G.G., Hulka B.S. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res. 1990, 10:1307-1311.
42. Wigington D.P., Strugnell S.A., Knutson J.C. Pamidronate and 1,24(S)-dihydroxyvitamin D2 synergistically inhibit the growth of myeloma, breast and prostate cancer cells. Anticancer Res. 2005, 25:1909-1917.
43. Takei T., Yoshida M., Ohnishi-Kameyama M., Kobori M. Ergosterol peroxide, an apoptosis-inducing component isolated from Sarcodon aspratus (Berk.) S. Ito. Biosci. Biotechnol. Biochem. 2005, 69:212-215.
44. Yasukawa K., Aoki T., Takido M., Ikekawa T., Saito H., Matsuzawa T. Inhibitory effects of ergosterol isolated from the edible mushroom Hypsizigus marmoreus on TPA-induced inflammatory ear oedema and tumour promotion in mice. Phytother. Res. 1994, 8:10-13.
45. Kim S., Park S., Min T., Yu K. Antioxidant activity of ergosterol peroxide (5,8-epidioxy-5α, 8α-ergosta-6, 22E-dien-3β-ol) in Armillariella mellea. Bull. Korean Chem. Soc. 1999, 20:819-823.
46. Kuo Y.C., Weng S.C., Chou C.J., Chang T.T., Tsai W.J. Activation and proliferation signals in primary human T lymphocytes inhibited by ergosterol peroxide isolated from Cordyceps cicadae. Br. J. Pharmacol. 2003, 140:895-906.
47. Tsugawa N., Okano T., Takeuchi A., Kayama M., Kobayashi T. Metabolism of orally administered ergosterol and 7-dehydrocholesterol in rats and lack of evidence for their vitamin D biological activity. J. Nutr. Sci. Vitaminol. 1992, 38:15-25.
48. Arceci R.J. Mechanism of resistance to therapy and tumor survival. Curr. Opin. Hematol. 1995, 2:268-274.
49. Denmeade S.R., Lin X.S., Isaacs J.T. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 1996, 28:251-265.
50. Nimmanapalli R., Perkins C.L., Orlando M., O'Bryan E., Nguyen D., Bhalla K.N. Pretreatment with paclitaxel enhances Apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res. 2001, 61:759-763.
51. Borner M.M., Myers C.E., Sartor O., Sei Y., Toko T., Trepel J.B., Schneider E. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res. 1995, 53:2122-2128.
52. Chen K., Kuo Y.H., Chiang B.H., Lo J.M., Sheen L.Y. Cytotoxic activities of 9,11-dehydroergosterol peroxide and ergosterol peroxide from the fermentation mycelia of Ganoderma lucidum cultivated in the medium containing leguminous plants on Hep 3B cells. J. Agric. Food Chem. 2009, 57:5713-5719.
53. Wochna A., Niemczyk E., Kurono C., Masaoka M., Kedzior J., Slominska E., Lipinski M., Wakabayashi T. A possible role of oxidative stress in the switch mechanism of the cell death mode from apoptosis to necrosis-studies on rho0 cells. Mitochondrion 2007, 7:119-124.
54. Kobori M., Yoshida M., Ohnishi-Kameyama M., Shinmoto H. Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells. Br. J. Pharmacol. 2007, 150:209-219.